NCT04556162View on ClinicalTrials.gov

Evaluation of Salt Status in Patients With Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

222

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

November 21, 2021

Study Completion Date

November 21, 2021

Conditions
Salt; Deficit (or Low)Cystic Fibrosis
Interventions
DIAGNOSTIC_TEST

fractional sodium excretion

fractional sodium excretion will be compared to urinary sodium/creatinin, sodium/potassium ratio's and sodium concentration.

OTHER

risk subgroups

subgroup analysis will be performed to identify the patient groups at risk for sodium depletion

Trial Locations (1)

9000

Gent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT04556162 - Evaluation of Salt Status in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter